JiShi Pharmaceutical-B (02616.HK) grants 4.8 million share options and 1.93 million restricted share units.

The China Fortune Financial News APP reported that cornerstone pharmaceuticals-B (02616.HK) announced that on August 27, 2025, the company had granted a total of 4.8 million warrants to subscribe for a total of 4.8 million shares to 5 warrant holders under the employee share ownership plan after the initial public offering; and granted a total of 1.93 million restricted share units to 5 restricted share unit holders under the restricted share unit award plan after the initial public offering, subject to acceptance by the recipients.